3D bioprinting for cancer modeling and drug screening.

Cadiou A, Peiller Matera EL, Ellinger N, Jordheim LP, Duruisseaux M, Marquette C, Dumontet C

Open source

DOI
10.1186/s40364-026-00951-x
Published
2026 Jun 20
Container
Biomarker research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40364-026-00951-x,
  title = {3D bioprinting for cancer modeling and drug screening.},
  author = {Cadiou A and Peiller Matera EL and Ellinger N and Jordheim LP and Duruisseaux M and Marquette C and Dumontet C},
  year = {2026},
  journal = {Biomarker research},
  doi = {10.1186/s40364-026-00951-x},
  url = {https://doi.org/10.1186/s40364-026-00951-x}
}

RIS

TY  - JOUR
TI  - 3D bioprinting for cancer modeling and drug screening.
AU  - Cadiou A
AU  - Peiller Matera EL
AU  - Ellinger N
AU  - Jordheim LP
AU  - Duruisseaux M
AU  - Marquette C
AU  - Dumontet C
PY  - 2026
JO  - Biomarker research
DO  - 10.1186/s40364-026-00951-x
UR  - https://doi.org/10.1186/s40364-026-00951-x
ER  - 

APA

A, C., EL, P. M., N, E., LP, J., M, D., C, M., & C, D. (2026). 3D bioprinting for cancer modeling and drug screening.. Biomarker research. https://doi.org/10.1186/s40364-026-00951-x

Source records